ConductScience.org, home

Gene · 7364

UGT2B7: UDP glucuronosyltransferase family 2 member B7

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. UGT2B7: UDP glucuronosyltransferase family 2 member B7. Genes, record 7364. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7364

On this page

Gene

Symbol
UGT2B7
HGNC
Name
UDP glucuronosyltransferase family 2 member B7
HGNC
NCBI Gene ID
7364
NCBI Gene
HGNC ID
HGNC:12554
HGNC
Ensembl
ENSG00000171234
NCBI Gene
Aliases
UDPGT 2B7, UDPGT 2B9, UDPGT2B7, UDPGTH2, UDPGTh-2, UGT2B9
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P16662UDP-glucuronosyltransferase 2B75291Ensembl, GeneID, HGNC

Source UniProt

Patents25

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1469140P16662Espacenet
EP 4650780 A22025-11-194306P16662Espacenet
EP 4640849 A22025-10-29562P16662Espacenet
EP 4641201 A22025-10-293849P16662Espacenet
JP 2025147176 A2025-10-0613909P16662Espacenet
JP 2025529142 A2025-09-045177P16662Espacenet
JP 2025529142 A2025-09-048004P16662Espacenet
US 12371689 B22025-07-295177P16662Espacenet
US 12371689 B22025-07-298004P16662Espacenet
JP 2025519096 A2025-06-24562P16662Espacenet

1 to 10 of 25

See all 25 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,118

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleUGT2B7 papersNewest fiscal year
P30AI050410The University of North Carolina Center for AIDS Research102025
R01HD081299Ontogeny of drug transport92025
R01AI077505Pharmacogenomics of HIV Therapy82025
ZIABC005562Xenobiotic receptors72025
ZIABC005708Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers72025
P30AI045008Penn Center for AIDS Research52025
P30ES013508Center of Excellence in Environmental Toxicology52025
R01CA080728Oncogenic Impact of eIF4E-dependent RNA Export in Cancer52025
R01CA098571Molecular Mechanisms of eIF4E Mediated Transformation52025
R35GM122576Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy52025

1 to 10 of 1,118Source NIH's project files

See all 1,118 nih grants

Papers2,547

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Respiratory depression with concomitant use of opioids and cannabinoids: a case report.Postgrad Med202642822008PubTator, text miningPubMed
Hypericin and hyperforin from St. John's Wort are potent intestinal UGT inhibitors with distinct binding modes: mechanistic and quantitative prediction of clinical drug-drug interaction risk.Front Pharmacol202642787300PubTator, text miningPubMed
Association of genetic polymorphisms with response to preoperative NSAIDs in endodontic postoperative pain: a randomized double-blind placebo-controlled clinical trial.Odontology202642763370PubTator, text miningPubMed
Impact of genetic polymorphisms on the response to transdermal fentanyl in cancer patients-a single-center, prospective, biological study.Front Pain Res (Lausanne)202642676478PubTator, text miningPubMed
Physiologically based pharmacokinetic modeling of fluconazole: interpretation of gender-dependent pharmacokinetics and cytochrome P450 inhibition.Front Pharmacol202642591558PubTator, text miningPubMed
The Pharmacogenomics of Opioid Response in Cancer Pain: From Receptor Polymorphisms to Tumour-Mediated Interference-A Narrative-Critical Review.Int J Mol Sci202642589662PubTator, text miningPubMed
Roles of Uridine Diphosphoglucuronosyltransferase 2B Enzymes in Cancer Susceptibility and Treatment: A Review.Pharmaceuticals (Basel)202642515700PubTator, text miningPubMed
Role of genetic polymorphisms on opioid safety and efficacy in cancer pain: A systematic review and meta-analysis.Eur J Pharmacol202642492880PubTator, text miningPubMed
Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy.Cancer Drug Resist202642433710PubTator, text miningPubMed
Utility of Relative Activity Factors to Determine Fraction Glucuronidation and Clearance of Icenticaftor in Humans.Pharm Res202642343021PubTator, text miningPubMed

1 to 10 of 2,547

See all 2,547 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/7364

GET https://conductscience.org/api/genes/v1/7364/patents?page=2